TD Cowen analyst Ritu Baral reiterated a Buy rating on Alto Neuroscience (NYSE: ANRO).The analyst commented, "ANRO held an IR ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE